622 related articles for article (PubMed ID: 29271940)
21. Tricin, 4',5,7-trihydroxy-3',5'-dimethoxyflavone, exhibits potent antiangiogenic activity in vitro.
Han JM; Kwon HJ; Jung HJ
Int J Oncol; 2016 Oct; 49(4):1497-504. PubMed ID: 27498749
[TBL] [Abstract][Full Text] [Related]
22. Antiangiogenic cancer therapy.
Cao Y
Semin Cancer Biol; 2004 Apr; 14(2):139-45. PubMed ID: 15018898
[TBL] [Abstract][Full Text] [Related]
23. Implications of flavonoids as potential modulators of cancer neovascularity.
Liskova A; Koklesova L; Samec M; Varghese E; Abotaleb M; Samuel SM; Smejkal K; Biringer K; Petras M; Blahutova D; Bugos O; Pec M; Adamkov M; Büsselberg D; Ciccocioppo R; Adamek M; Rodrigo L; Caprnda M; Kruzliak P; Kubatka P
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3079-3096. PubMed ID: 32902794
[TBL] [Abstract][Full Text] [Related]
24. Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies.
Bottsford-Miller JN; Coleman RL; Sood AK
J Clin Oncol; 2012 Nov; 30(32):4026-34. PubMed ID: 23008289
[TBL] [Abstract][Full Text] [Related]
25. Tumor angiogenesis inhibitors.
Kiselev SM; Lutsenko SV; Severin SE; Severin ES
Biochemistry (Mosc); 2003 May; 68(5):497-513. PubMed ID: 12882631
[TBL] [Abstract][Full Text] [Related]
26. Antiangiogenic therapy for cancer: current and emerging concepts.
Jain RK
Oncology (Williston Park); 2005 Apr; 19(4 Suppl 3):7-16. PubMed ID: 15934498
[TBL] [Abstract][Full Text] [Related]
27. Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer.
Welti J; Loges S; Dimmeler S; Carmeliet P
J Clin Invest; 2013 Aug; 123(8):3190-200. PubMed ID: 23908119
[TBL] [Abstract][Full Text] [Related]
28. Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer.
WalyEldeen AA; Sabet S; El-Shorbagy HM; Abdelhamid IA; Ibrahim SA
Chem Biol Interact; 2023 Jan; 369():110297. PubMed ID: 36496109
[TBL] [Abstract][Full Text] [Related]
29. Antiangiogenic compounds: well-established drugs versus emerging natural molecules.
Ribeiro A; Abreu RMV; Dias MM; Barreiro MF; Ferreira ICFR
Cancer Lett; 2018 Feb; 415():86-105. PubMed ID: 29222042
[TBL] [Abstract][Full Text] [Related]
30. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
31. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of selected flavonoids as antiangiogenic, anticancer, and radical scavenging agents: an experimental and in silico analysis.
Gacche RN; Shegokar HD; Gond DS; Yang Z; Jadhav AD
Cell Biochem Biophys; 2011 Dec; 61(3):651-63. PubMed ID: 21830125
[TBL] [Abstract][Full Text] [Related]
33. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
Oh SH; Woo JK; Jin Q; Kang HJ; Jeong JW; Kim KW; Hong WK; Lee HY
Int J Cancer; 2008 Jan; 122(1):5-14. PubMed ID: 17764071
[TBL] [Abstract][Full Text] [Related]
34. Direct Effects of Anti-Angiogenic Therapies on Tumor Cells: VEGF Signaling.
Simon T; Gagliano T; Giamas G
Trends Mol Med; 2017 Mar; 23(3):282-292. PubMed ID: 28162910
[TBL] [Abstract][Full Text] [Related]
35. Imaging tumor angiogenesis.
Red-Horse K; Ferrara N
J Clin Invest; 2006 Oct; 116(10):2585-7. PubMed ID: 17016553
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in vascular disrupting agents in cancer therapy.
Porcù E; Bortolozzi R; Basso G; Viola G
Future Med Chem; 2014 Sep; 6(13):1485-98. PubMed ID: 25365233
[TBL] [Abstract][Full Text] [Related]
37. Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model.
Jain RK; Tong RT; Munn LL
Cancer Res; 2007 Mar; 67(6):2729-35. PubMed ID: 17363594
[TBL] [Abstract][Full Text] [Related]
38. Nutraceuticals as anti-angiogenic agents: hopes and reality.
Dulak J
J Physiol Pharmacol; 2005 Mar; 56 Suppl 1():51-67. PubMed ID: 15800385
[TBL] [Abstract][Full Text] [Related]
39. Flavonoids from the leaves of Carya cathayensis Sarg. inhibit vascular endothelial growth factor-induced angiogenesis.
Tian SS; Jiang FS; Zhang K; Zhu XX; Jin B; Lu JJ; Ding ZS
Fitoterapia; 2014 Jan; 92():34-40. PubMed ID: 24096161
[TBL] [Abstract][Full Text] [Related]
40. Review of selected patents for cancer therapy targeting tumor angiogenesis.
Kirstein MN; Moore MM; Dudek AZ
Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):153-61. PubMed ID: 18221033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
